ReviewCancers2023
Emerging Targeted Therapies for HER2-Positive Breast Cancer.
María Florencia Mercogliano et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
96 papers cite itlatest 60 shown
this paperpooled ittrialcites it
ReviewCancers2023
María Florencia Mercogliano et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.